A broad scope, a broad readership, and a broad purpose

The long battle with cancer began centuries ago and despite many victories, the overall incidence continues to rise and it sometimes feels like that we are losing the war. The high rates and mortality of cancer have brought an increasing burden to society and so defeating the disease remains an urgent and unmet clinical need. In recent years, there has been a profound development of new knowledge and technologies that are widely employed in cancer research across multiple disciplines and even moreso, across the world. In modern times, it is hard to keep up with these breakthroughs, especially when they occur in varying regions. To address this, we are delighted to announce the launch of Malignancy Spectrum (MSP) in a bid to bring global advances in these disciplines together in one place.

MSP is an international open-access journal that intends to publish cutting-edge research in cancer biology and translational sciences that should be beneficial to the field of cancer research and clinical practice. The mission of MSP is to influence global cancer research and make contributions to an understanding of cancer biology and the development of novel therapeutic approaches by publishing peer-reviewed original research and thought-provoking reviews that accelerate the conversion application from bench-side to bed-side.

The content published in MSP will reach a broad range of scientists and clinicians across the field of cancer research. MSP publishes research articles in three categories: fundamental or translational research; clinical trials or epidemic cohorts; and novel biomedical technologies that would promote the development of cancer research.

We encourage submissions presenting innovative findings that create new directions in the research of cancer biology, as well as investigations that enrich our understanding of cancer prevention, clinical diagnosis, and treatment. This includes, but is not limited to, fundamental and translational work, clinical trials in all areas of cancer including studies in cancer genomics and tumor biomarkers, and developments in therapeutic approaches that contribute to prevention, diagnostics, treatment, and healthcare. We will also publish reviews that cover recent literature and author's options in such exciting fields.

MSP is dedicated to building a bridge and applying a platform for communications between scientists, clinicians, and readers, including nonexperts who are interested in the field of oncology research. We are eager to collaborate with authors and reviewers to produce the best clinical and translational advances. MSP's professional in-house scientific editors work closely with authors, reviewers, and the journal's editorial board to ensure an efficient editorial process, fair and robust peer review, and rapid dissemination and communication of your research.

We highly appreciate your support in MSP and wish to work together with you to build a wonderful academic platform for serving the international cancer community in the future.